About this conference
Brain tumor care advances with IDH-targeted therapies and the maturing immunotherapy landscape is a 2-day conference in Prague, Czech Republic on 22–23 Jun 2027. Abstract deadline: 17 Jun 2027. Organizer: neuroscience.
Brain tumor care advances with IDH-targeted therapies and the maturing immunotherapy landscape. The session covers vorasidenib in IDH-mutant glioma (INDIGO phase 3), ivosidenib and combination approaches, glioblastoma post-Stupp with TTFields (Optune), brain metastases management including stereotactic radiosurgery and whole-brain radiation alternatives, CSF ctDNA in CNS lymphoma and metastases, and immunotherapy in CNS tumours (the limited but emerging evidence).